000			03012nas a22003255i 4500
001			1528-3658
003			DE-He213
005			20260304140540.0
007			cr nn 008mamaa
008			170822s||||||||xxkuu poo|||||| b|EN |d
022			_a1528-3658
024	7		_a10020 _2local
210	1	0	_aMol Med
245	1	0	_aMolecular Medicine _h[electronic resource] / _cedited by Betty Diamond, Valentin A Pavlov, Maria Ruggieri, Shabirul Haque, Sonya VanPatten.
264		1	_aLondon : _bBioMed Central : _bImprint: BioMed Central.
300			_bonline resource.
520			_aMolecular Medicine is an open access journal publishing recent findings that elucidate disease pathogenesis at the molecular or physiological level, which may lead to the design of specific tools for disease diagnosis, treatment, or prevention. Manuscripts containing material relevant to the genetic, molecular, or cellular basis of key physiologic or disease processes are considered for publication. Manuscripts submitted to Molecular Medicine should describe the implications of the results for human disease and medicine, at a level approachable by our broad audience. Criteria to consider for studies involving lnc-RNAs or micro-RNAs: · As lncRNAs and miRNAs have multiple targets, claims of their function mediated by a single target or pathway will not be accepted, unless multiple additional targets are investigated to support functional specificity. · The rationale to investigate a specific lncRNA or miRNA needs to be specified upfront in the introduction and justified in the context of other miRNAs known to be functional in that specific field. · The proposed function of the lnc-RNA or miRNA should be validated by gain and loss of function studies. · Primary cells should be used whenever possible to confirm findings in cell lines. · In depth investigation in the signaling pathway(s) regulated by the RNA species should be conducted. · Insight into the regulation of the RNA species and how it relates to the pathologic state should be provided. · If applicable: Details of initial screen used to identify RNA species involvement in pathway/disease (number of subjects, statistical tests employed, percent change from controls).
650		0	_aMedicine—Research.
650		0	_aBiology—Research.
650	1	4	_aBiomedical Research.
700	1		_aDiamond, Betty. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _923995
700	1		_aPavlov, Valentin A. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _923996
700	1		_aRuggieri, Maria. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _923997
700	1		_aHaque, Shabirul. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _923998
700	1		_aVanPatten, Sonya. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _923999
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted version: _x1076-1551
856	4	0	_uhttps://molmed.biomedcentral.com _zOpen Access
999			_c460016 _d460016